Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ANIP

ANI PHARMACEUTICALS INC

Healthcare · Pharmaceutical Preparations

$74.43Sep 23, 2026

AI confidence 70% · refreshes every 15s during session

Investment Snapshot

Weak evidence · 1 source

Why it matters

ANI PHARMACEUTICALS INC shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +26% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +26% YoY in Q2 FY2026

Pipeline evidence · 22d ago

ANIP's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ANIP.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full ANIP earnings analysis

Reported figures for ANI PHARMACEUTICALS INC — research only, not investment advice.

Revenue YoY
+25.9%
EPS YoY
+191.7%

Latest Intelligence

Updated

What happened recently for ANI PHARMACEUTICALS INC (ANIP) — events, not interpretation.

Event
Reported Q2 2026 revenue +26% YoY.
Also
Last session September 23, 2026 at $74.43.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

ANI PHARMACEUTICALS INC (ANIP)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for ANI PHARMACEUTICALS INC — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$1.82B
Revenue:
$266.04M

ANIP earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow ANI PHARMACEUTICALS INC through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.